首页> 外文期刊>Toxicology: An International Journal Concerned with the Effects of Chemicals on Living Systems >Identification of an abnormal beryllium lymphocyte proliferation test.
【24h】

Identification of an abnormal beryllium lymphocyte proliferation test.

机译:鉴定异常的铍淋巴细胞增殖测试。

获取原文
获取原文并翻译 | 示例
           

摘要

The potential hazards from exposure to beryllium or beryllium compounds in the workplace were first reported in the 1930s. The tritiated thymidine beryllium lymphocyte proliferation test (BeLPT) is an in vitro blood test that is widely used to screen beryllium exposed workers in the nuclear industry for sensitivity to beryllium. The clinical significance of the BeLPT was described and a standard protocol was developed in the late 1980s. Cell proliferation is measured by the incorporation of tritiated thymidine into dividing cells on two culture dates and using three concentrations of beryllium sulfate. Results are expressed as a 'stimulation index' (SI) which is the ratio of the amount of tritiated thymidine (measured by beta counts) in the simulated cells divided by the counts for the unstimulated cells on the same culture day. Several statistical methods for use in the routine analysis of the BeLPT were proposed in the early 1990s. The least absolute values (LAV) method was recommended for routine analysis of the BeLPT. This report further evaluates the LAV method using new data, and proposes a new method for identification of an abnormal or borderline test. This new statistical-biological positive (SBP) method reflects the clinical judgment that: (i) at least two SIs show a 'positive' response to beryllium; and (ii) that the maximum of the six SIs must exceed a cut-point that is determined from a reference data set of normal individuals whose blood has been tested by the same method in the same serum. The new data is from the Y-12 National Security Complex in Oak Ridge (Y-12) and consists of 1080 workers and 33 non-exposed control BeLPTs (all tested in the same serum). Graphical results are presented to explain the statistical method, and the new SBP method is applied to the Y-12 group. The true positive rate and specificity of the new method were estimated to be 86% and 97%, respectively. An electronic notebook that is accessible via the Internet was used in this work and contains background information and details not included in the paper.
机译:在1930年代首次报道了工作场所接触铍或铍化合物引起的潜在危害。 ti化胸苷铍淋巴细胞增殖测试(BeLPT)是一种体外血液测试,已广泛用于核工业中接触铍的工作人员对铍的敏感性。描述了BeLPT的临床意义,并在1980年代后期制定了标准协议。通过在两个培养日期将of化的胸苷掺入分裂的细胞中并使用三种浓度的硫酸铍来测量细胞增殖。结果表示为“刺激指数”(SI),即模拟细胞中tri化胸腺嘧啶核苷的量(通过β计数测量)除以同一培养日未刺激细胞的计数之比。 1990年代初提出了几种用于BeLPT常规分析的统计方法。建议对BeLPT进行常规分析时使用最小绝对值(LAV)方法。该报告进一步使用新数据评估了LAV方法,并提出了一种用于识别异常或临界测试的新方法。这种新的统计生物学阳性(SBP)方法反映了以下临床判断:(i)至少两个SI对铍表现出“阳性”反应; (ii)六个SI的最大值必须超过一个临界点,该临界点是由正常人的参考数据集确定的,该正常人的血液已通过相同方法在同一血清中进行了测试。新数据来自橡树岭(Y-12)的Y-12国家安全中心,包括1080名工人和33个未暴露的对照BeLPT(均在同一血清中测试)。给出图形结果来解释统计方法,并将新的SBP方法应用于Y-12组。新方法的真实阳性率和特异性估计分别为86%和97%。这项工作使用了可通过互联网访问的电子笔记本,其中包含背景信息和本文未包括的详细信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号